Skip to main content
. 2018 May 29;5(6):ofy125. doi: 10.1093/ofid/ofy125

Table 5.

Recommended Durations of Secondary Prophylaxis According to Major International Guidelines

Guideline Secondary Prophylaxis Duration Recommended
Australian (2012) [10] • In all patients for at least 10 y after previous ARF
• Severe RHD until age 40 y or indefinitely, per physician discretion
• Moderate RHD or RHD without prior documented ARF date until age 35 y
• Mild RHD or ARF without RHD diagnosis until age 21 y or for 10 y after last ARF (whichever is longer)
New Zealand (2014) [16] • After definite/probable ARF, continue prophylaxis for at least 10 y, consider 5 y of prophylaxis after ARF in patients with mild or no carditis over 21 y or in patients with ARF classified as “possible”
• Severe RHD generally until age 40 y, with review at age 30 ya
• Moderate RHD until age 30 ya
• Mild RHD or ARF without RHD diagnosis, until age 21 y or for 10 y after last ARF (whichever is longer)
American (AHA 2009) [17] • ARF with carditis and residual heart disease until age 40 y or for 10 y after last ARF (whichever is longer); lifetime prophylaxis may be needed
• ARF with carditis but no residual heart disease until age 21 y or for 10 y after last ARF (whichever is longer)
• ARF without carditis until age 21 y or for 5 y after last ARF (whichever is longer)
Indian (2008) [18] • Lifelong in severe disease or postintervention patients; may opt for secondary prophylaxis until age 40 y
• ARF with healed, mild, or moderate carditis until age 25 y or for 10 y after last ARF (whichever is longer)
• ARF without carditis until age 18 y or for 5 y after last ARF (whichever is longer)
WHO Expert Consultation Geneva (2001) [15] • Lifelong if severe valvular disease or after valve surgery
• For 10 y after last ARF or until age 25 y in patients with previous diagnosis of carditis
• For 5 y after last ARF or until age 18 y in patients without proven carditis

Abbreviations: ARF, acute rheumatic fever; RHD, rheumatic heart disease.

aFor severe RHD at age 40 years or moderate RHD at age 30 years, cessation of prophylaxis is still at the physician’s discretion based on the individual patient risk.